A bill to establish a Federal multi-agency task force to combat illegal importation, distribution, and sale of e-cigarettes.
SB 3569, the “S.T.O.P. Illicit Vapes Act,” would create or reestablish a federal multi-agency task force focused on combating the illegal importation, distribution, and sale of e-cigarettes. The task force would be co-chaired by the Attorney General and the Secretary of Health and Human Services and would include representatives from FDA, DOJ, Customs and Border Protection, ATF, the U.S. Marshals Service, the Postal Inspection Service, the FTC, Homeland Security Investigations, the FBI, and other relevant federal agencies.
The task force would be required to develop and carry out a comprehensive strategy to reduce unauthorized e-cigarettes in the market, including setting goals, sharing information, and coordinating enforcement efforts. It would meet at least monthly and submit semiannual reports to Congress describing each agency’s authorities and enforcement actions, including criminal, civil, seizure, and forfeiture actions, as well as recommendations for additional legal authorities and improvements in interagency coordination. The task force would sunset 10 years after establishment.
The bill would not directly regulate e-cigarettes through new product standards or taxes, but it would strengthen federal enforcement coordination against illicit vape products. It would affect the operational responsibilities of multiple federal agencies and require regular reporting to Congress, potentially leading to more investigations, prosecutions, seizures, forfeitures, and border/interdiction actions against unauthorized manufacturers, importers, and distributors. It could also prompt future legislative changes if the task force recommends additional criminal or civil authorities.
Based on the bill text and the available context, the measure appears to have a generally enforcement-oriented, bipartisan tone, as it was introduced by Senators Durbin and Tillis. There are no recorded committee transcripts or votes in the provided material, so there is no evidence of formal opposition or support beyond the bipartisan sponsorship and the bill’s referral to committee.
The main policy tension is likely between public health and enforcement priorities on one side and concerns about federal overreach, regulatory burden, or the adequacy of existing authorities on the other. The bill itself anticipates that current authorities may be insufficient by directing the task force to identify gaps and recommend additional powers. Because no hearing record or votes are provided, no specific member, agency, or stakeholder objections can be identified from the supplied materials.